Video

Patient-to-Patient: What to Expect in a Clinical Trial

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Freeman-Daily says that clinical trials are especially important for patients like her who have metastatic lung cancer, for which there is currently no cure but a number of options and clinical trials that may benefit patients.

Before joining a clinical trial, patients should know their risk and understand the difference between each of the three phases of clinical trials. Also, patients should never think that they may not be treated in a clinical trial. Even if randomized to placebo, they will always get the best standard of care.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.